Cover Image
市場調查報告書

糖尿病:穿戴式行動醫療設備市場概要

Diabetes: Wearable mHealth Device Market Overview

出版商 ABI Research 商品編碼 374091
出版日期 內容資訊 英文 23 Pages, 5 Tables, 7 Charts, 1 Figure
商品交期: 最快1-2個工作天內
價格
如有價格方面的疑問請按下「詢問」鍵來信查詢
Back to Top
糖尿病:穿戴式行動醫療設備市場概要 Diabetes: Wearable mHealth Device Market Overview
出版日期: 2016年10月11日 內容資訊: 英文 23 Pages, 5 Tables, 7 Charts, 1 Figure
簡介

本報告提供糖尿病穿戴式設備市場及這些設備、平台引進的進步與發展的相關調查,持續性血糖監測系統 (CGM) 設備的出貨、收益,主要的設備製造商簡介,及糖尿病穿戴式設備預測等系統性資訊。

第1章 流行病的治療

  • 糖尿病與其影響
  • 傳統的血糖監測系統
  • 持續的血糖監測系統
  • 糖尿病治療設備的未來:從CGM到穿戴式設備及人工胰臟

第2章 持續的血糖監測系統 (CGM) 市場

  • 設備的出貨
  • 設備的收益
  • 地區的出貨、收益

第3章 主要連續血糖監測供應商

  • 市售的CGM以及其他的糖尿病管理產品
  • 傳統儀表製造商企業簡介
  • 主要的糖尿病患者設備企業簡介
  • 關注的CGM生態系統企業簡介
  • 智慧型手機飾品及糖尿病檢查裝置
  • 糖尿病穿戴式設備的未來
目錄
Product Code: AN-1552

By the end of 2016, the number of diabetics worldwide will pass the half a billion mark. Diabetics need to frequently monitor their blood sugar or blood glucose levels in order to prevent the disease from causing greater harm. In the United States, the average diabetic spends US$8650 a year just on these diabetic treatments. Traditionally, this manifested itself by users pricking their several times a day with lancing devices in order to get a drop of blood that can be tested with a glucose meter. Wearable wireless devices are currently on the market though that ease this process for diabetics. Continuous glucose monitors (CGM) and insulin pumps help measure glucose levels from fluid under the skin. The readings from CGMs can then be used to advise the diabetic what course of action to take, or in the case of emergencies, can be sent immediately to healthcare providers.

Currently, mHealth CGM devices are being primarily used in the North American and European markets. There will be increasing opportunities in emerging markets as the number of diabetics throughout Asia, Africa, and the Middle East continues to rise and places a rising burden on regional healthcare systems. This presents an enormous market opportunity for companies to create more efficient treatment devices, in terms of both ease of use and cost, that will help diabetics to properly manage their condition.

This analysis examines progress and development in the diabetes wearable device market and the adoption of these devices and platforms. Leading device manufacturers are profiled along with progress they are expected to make over the next five years and beyond. The analysis suggests what difficulties there are with the adoption of these devices and what future devices will be available to help treat the nearly half a billion diabetics worldwide who will have the disease by 2021.

Table of Contents

1. TREATING AN EPIDEMIC

  • 1.1. DIABETES AND ITS IMPACT
  • 1.2. TRADITIONAL GLUCOSE MONITORING
  • 1.3. CONTINUOUS GLUCOSE MONITORING
  • 1.4. THE FUTURE OF DIABETES TREATMENT DEVICES: FROM CGM TO WEARABLES AND THE ARTIFICIAL PANCREAS

2. THE CONTINUOUS GLUCOSE MONITORING MARKET

  • 2.1. DEVICE SHIPMENTS
  • 2.2. DEVICE REVENUE
  • 2.3. REGIONAL SHIPMENTS AND REVENUE

3. KEY CONTINUOUS GLUCOSE MONITOR VENDORS

  • 3.1. CGM AND OTHER DIABETES MANAGEMENT PRODUCTS ON THE MARKET
  • 3.2. TRADITIONAL METER MANUFACTURER COMPANY PROFILES
  • 3.3. MAJOR DIABETES PATIENT EQUIPMENT PLAYERS COMPANY PROFILES
  • 3.4. NOTABLE CGM ECOSYSTEM COMPANY PROFILES
  • 3.5. SMARTPHONE ACCESSORIES AND DIABETES TESTING DEVICES
  • 3.6. THE FUTURE OF DIABETES WEARABLE DEVICES
Back to Top